Sakata, Y., Kawamura, K., Shingu, N., Hiroshige, S., Yasuda, Y., Eguchi, Y., . . . Ichikado, K. (2018). The effects of switching EGFR‐TKI treatments for non‐small cell lung cancer because of adverse events. Asia Pac J Clin Oncol.
استشهاد بنمط شيكاغوSakata, Yoshihiko, et al. "The Effects of Switching EGFR‐TKI Treatments for Non‐small Cell Lung Cancer Because of Adverse Events." Asia Pac J Clin Oncol 2018.
MLA استشهادSakata, Yoshihiko, et al. "The Effects of Switching EGFR‐TKI Treatments for Non‐small Cell Lung Cancer Because of Adverse Events." Asia Pac J Clin Oncol 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.